Today, NORD issued a press release regarding how registries and natural history studies, like ours, are keys to understanding rare conditions and can help accelerate advancements that uncover new treatments. We are excited to be part of this group of rare disease foundations and thank NORD for its continued support of The APS Type 1 (APECED) Registry.

To enroll in our registry, click here.

Read the full press release.

Leave a Reply

Your email address will not be published.